Usana Health Sciences Inc (STU:USJ)
€ 18.9 -0.30 (-1.56%) Market Cap: 357.80 Mil Enterprise Value: 272.38 Mil PE Ratio: 47.06 PB Ratio: 0.75 GF Score: 67/100

Q3 2025 USANA Health Sciences Inc Earnings Call Transcript

Oct 23, 2025 / 03:00PM GMT
Release Date Price: €15 (-15.73%)

Key Points

Positve
  • Usana Health Sciences Inc (USNA) has successfully rolled out an enhanced compensation plan designed to improve brand partner success and engagement.
  • The company has seen a recent lift in sales activity and leader productivity, particularly after their global convention in August.
  • Usana Health Sciences Inc (USNA) is making strategic investments in in-house manufacturing, which is expected to improve margins and control over inventory levels.
  • The company's venture companies, HIA and Rise Bar, have shown significant sales growth, with Rise Bar reporting a 169% increase in year-to-date net sales.
  • Usana Health Sciences Inc (USNA) is executing a global cost reduction process to create a more agile and adaptable organization, which is expected to result in long-term operational efficiencies.
Negative
  • The third quarter results were impacted by softer sales and brand partner productivity leading up to the global convention.
  • There was a reported increase in inventories, partly due to new product introductions and investments in venture companies, which could affect cash flow.
  • The direct-to-consumer business, HIA, experienced challenges in top-line growth during the third quarter.
  • The company anticipates incurring a one-time charge of $4.7 million in the fourth quarter due to the global cost reduction process.
  • The direct selling industry has struggled post-COVID, and Usana Health Sciences Inc (USNA) faces challenges in differentiating its product offerings in a competitive market.
Operator

Greetings and welcome to the Usana Health Sciences third quarter earnings call. (Operator Instructions)

I will now turn the conference over to your host Andrew Masuda, director of investor relations.

Thank you. You may begin.

Andrew Masuda
Usana Health Sciences Inc - Director of investor relations

Thanks Diego and good morning, everyone. We appreciate you joining us to review our third quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at IR.Usana.com.

Shortly following the call, replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking statements.

Examples of these statements include those regarding our strategies and outlook for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot